Evidence map›Paper›PMID 39303853›Full record

ArticleJournal of molecular and cellular cardiology2024

Cardiac macrophages and fibroblasts: A synergistic partnership without cellular transition.

Daniel A Kasprovic, Robert M Jaggers, Michael Tranter, Onur Kanisicak

Abstract readEditorial
In one paragraph

Article in Journal of molecular and cellular cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel A KasprovicDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Department of Molecular Medicine and Therapeutics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Robert M JaggersDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Michael TranterDorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Department of Molecular Medicine and Therapeutics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Onur KanisicakDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Electronic address: Onur.Kanisicak@osumc.edu.

Funding

Post-transcriptional control of adipose tissue gene expression as an endocrine mediator of cardiac pathologyR01HL158671 · NHLBI · UNIVERSITY OF CINCINNATI · PI Michael Tranter · 2022 to 2026
$3.1M
Functional and mechanistic delineation of HuR-Wisp1 signaling on myofibroblast activityR01HL166326 · NHLBI · UNIVERSITY OF CINCINNATI · PI Onur Kanisicak, Michael Tranter · 2023 to 2026
$2.6M
Aspergillus fumigatus infection and fibrosisR01AI159078 · NIAID · UNIVERSITY OF CINCINNATI · PI ASKEW, DAVID S, KANISICAK, ONUR · 2021 to 2025
$2.0M
Regulators of extracellular matrix production during cardiac development and diseaseR01HL148598 · NHLBI · UNIVERSITY OF CINCINNATI · PI KANISICAK, ONUR · 2020 to 2024
$2.0M
NHLBI NIH HHS R01 HL148598NHLBI NIH HHS R01 HL158671NHLBI NIH HHS R01 HL166326NIAID NIH HHS R01 AI159078
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiac remodelingCellular transitionFibroblastHeartMacrophage

Identifiers

PMID39303853
PMCPMC12015549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.